“The low rates of hepatitis C virus (HCV) screening in real-world practice indicate the existence of barriers that need to be overcome. In addition to the COVID-19 pandemic causing delays and/or discontinuations in many hepatitis elimination efforts, there are barriers on the provider level, such as communication challenges, low awareness of HCV, and poor knowledge of HCV screening recommendations. Patient-level barriers include lack of knowledge and awareness of HCV infection, confusion about transmission, and lack of insurance to pay for screening. It is essential that clinicians who treat patients with HCV are aware of these barriers and are equipped with strategies to overcome them in order to ensure screening and optimal management of all populations at risk for HCV infection.

This live Q&A session is your opportunity to ask questions based on the CME Outfitters BriefCase series covering the latest guideline recommendations and evidence supporting optimal management of complex HCV cases.

Learning Objectives

At the end of this CME/CE activity, participants should be able to:

• Implement CDC screening guidelines in practice to improve the detection and diagnosis of HCV.

• Apply efficacy and safety data to treatment decisions for optimal management of HCV.

• Integrate routine surveillance for HCC into clinical follow-up for patients with HCV.”